Related Experiment Video
Updated: Oct 3, 2025
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Recent Technological Innovations to Promote Cardiovascular Research
1Department of Cardiology, Keio University School of Medicine.
Insights
Induced pluripotent stem (iPS) cells and artificial intelligence (AI) offer new ways to study cardiovascular diseases (CVDs). These technologies provide novel insights for developing innovative treatments for severe CVD.
Area of Science:
- Biomedical Research
- Regenerative Medicine
- Computational Biology
Background:
- Cardiovascular diseases (CVDs) represent a significant global health challenge.
- Current treatments for severe CVDs, including medications and transplantation, remain insufficient.
- Understanding CVD pathophysiology is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in cardiovascular research utilizing induced pluripotent stem (iPS) cells and artificial intelligence (AI).
- To highlight the potential of iPS cells and AI in uncovering new insights into CVDs.
- To explore innovative treatment approaches for cardiovascular diseases.
Main Methods:
- Review of current literature on iPS cell technology in cardiovascular research.
- Analysis of AI applications in big data analysis for basic cardiovascular research.
- Integration of findings from iPS cell-based disease modeling and AI-driven insights.
Main Results:
- iPS cell technology enables disease modeling in vitro, using patient-derived cells for genetic disorders.
- AI facilitates big data analysis, offering potential applications in cardiovascular medicine.
- The combination of iPS cells and AI provides novel perspectives for understanding and treating CVDs.
Conclusions:
- iPS cells and AI are powerful tools for advancing cardiovascular disease research.
- These technologies hold promise for developing personalized regenerative therapies and novel drug discovery for CVDs.
- Further research integrating iPS cells and AI is essential for overcoming limitations in current CVD treatment.
Abstract:
Cardiovascular disease (CVD) is a major global health concern. Several therapeutic strategies for CVDs are available, such as medicine, cardiac assist devices, and heart transplantation. However, they are insufficient for the treatment of severe CVD. To develop novel, innovative treatment approaches for CVDs, it is imperative to understand the underlying pathophysiology and to undertake basic research on this facet. The generation of induced pluripotent stem (iPS) cells has opened avenues for developing new strategies for disease analysis and drug development. This technology has made it possible to obtain pluripotent stem cells from patients with genetic disorders, model the disease in a dish, and use such cells for future regeneration therapy. Meanwhile, artificial intelligence (AI), which is widely used for big data analysis in basic research, has potential in various applications in medicine. New tools such as iPS cells and AI can provide much needed novel insights into CVDs. This review focuses on the recent progress in cardiovascular research using these new technologies.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:26Coronary Artery Disease IV: Preventive Measures